CDK9-IN-31 (dimaleate)
Product Specifications
UNSPSC Description
CDK9-IN-31 dimaleate (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 dimaleate has the potential to be developed as an anticancer agent[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-31-dimaleate.html
Solubility
10 mM in DMSO
Smiles
O=C(O)/C=C\C(O)=O.OC[C@@H](C)N[C@@H](CC1)CC[C@H]1NC2=CC(C3=CSC(NCC4(CCOCC4)C#N)=N3)=C(Cl)C=N2.O=C(O)/C=C\C(O)=O
Molecular Weight
737.22
References & Citations
[1]Fusheng Zhou, et al. CDK9 inhibitor and preparation method and application thereof. Patent CN116496267A.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-160171A/CDK9-IN-31-dimaleate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-160171A/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1096719-01 0.02 mg (E-Coli)
Recombinant Bacillus megaterium Cobyrinic acid A,C-diamide synthase (cobB)
Ask
View Details